A retrospective cohort study was conducted using data from January 1, 2004, to December 31, 2018. The researchers reviewed information from the FDA and the European Medicines Agency (EMA) to determine...
Psilocybin, a chemical compound derived from mushrooms, has been a topic of interest for researchers focused on neuropsychiatric conditions, specifically substance use disorders. A double-blind,...
Recently, the FDA approved the sale of some over-the-counter (OTC) hearing aids, widening access to those who need them. According to the National Institute on Deafness and Other Communication...
A recent study in JAMA Open Network looked at the relationship between fluoroquinolone — an antibiotic — dosage and adverse side effects in patients with CKD. The researchers found that...
A cohort study in JAMA Network Open analyzed the efficacy of the COVID-19 vaccine in preventing SARS-CoV-2 reinfection. The study found that COVID-19 vaccination reduced reinfection rates by...
Unintended pregnancy threatens public health and is exacerbated by limited access and understanding of female contraceptives. The CDC identifies unintended pregnancy as “a pregnancy that is either unwanted, such as the...
According to a cross-sectional survey study published in JAMA, remote and decentralization tools can improve clinical trial enrollment and participation in cancer studies.
Recently, many...
The overturning of Roe v. Wade by the United States Supreme Court has left many people anxious about access to reproductive healthcare. Earlier this week, the HHS established guidelines for retail...
HRA Pharma has submitted an FDA application to allow the OTC sale of their progestin-only daily birth control pill, Opill. If this application is approved, this will be the first birth control pill...
The Journal of the American Medical Association recently published an updated recommendation from the USTPF on using vitamins and supplements to prevent cardiovascular disease and cancer. The study...
The American Medical Association (AMA) recently strongly supported the Biden Administration's proposal for Medicare Advantage (MA) and prescription drug benefit policies in an official letter.
In...
